NO2001014I2 - Symbicort turbuhaler - Google Patents

Symbicort turbuhaler

Info

Publication number
NO2001014I2
NO2001014I2 NO2001014C NO2001014C NO2001014I2 NO 2001014 I2 NO2001014 I2 NO 2001014I2 NO 2001014 C NO2001014 C NO 2001014C NO 2001014 C NO2001014 C NO 2001014C NO 2001014 I2 NO2001014 I2 NO 2001014I2
Authority
NO
Norway
Prior art keywords
budesonide
separately
symbicort
tails
turbo
Prior art date
Application number
NO2001014C
Other languages
English (en)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8208509&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO2001014(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO2001014I2 publication Critical patent/NO2001014I2/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Control Of Positive-Displacement Air Blowers (AREA)
  • Fats And Perfumes (AREA)
  • Heat Treatment Of Sheet Steel (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Edible Oils And Fats (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO2001014C 1991-12-18 2001-07-31 Symbicort turbuhaler NO2001014I2 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91311761 1991-12-18
PCT/EP1992/002826 WO1993011773A1 (en) 1991-12-18 1992-12-07 New combination of formoterol and budesonide

Publications (1)

Publication Number Publication Date
NO2001014I2 true NO2001014I2 (no) 2007-06-11

Family

ID=8208509

Family Applications (2)

Application Number Title Priority Date Filing Date
NO942116A NO306452B1 (no) 1991-12-18 1994-06-07 Medisinsk kombinasjonsprodukt omfattende formoterol og budesonid, produkt for behandling av respiratorisk forstyrrelse og astma ved inhalering, farmasöytisk preparat, törrpulverinhalator og kapsel for denne, og anvendelse av nevnte preparat
NO2001014C NO2001014I2 (no) 1991-12-18 2001-07-31 Symbicort turbuhaler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO942116A NO306452B1 (no) 1991-12-18 1994-06-07 Medisinsk kombinasjonsprodukt omfattende formoterol og budesonid, produkt for behandling av respiratorisk forstyrrelse og astma ved inhalering, farmasöytisk preparat, törrpulverinhalator og kapsel for denne, og anvendelse av nevnte preparat

Country Status (20)

Country Link
US (2) US5674860A (no)
JP (1) JP3342484B2 (no)
AT (1) ATE213946T1 (no)
AU (1) AU673660C (no)
CA (2) CA2356145A1 (no)
CZ (2) CZ288032B6 (no)
DE (2) DE69232462T2 (no)
DK (1) DK0613371T3 (no)
ES (1) ES2172510T3 (no)
HR (1) HRP921445B1 (no)
HU (2) HU227519B1 (no)
IS (1) IS3959A (no)
NO (2) NO306452B1 (no)
NZ (1) NZ246050A (no)
PT (1) PT613371E (no)
SG (1) SG48301A1 (no)
SI (1) SI9200403B (no)
SK (2) SK282826B6 (no)
WO (1) WO1993011773A1 (no)
YU (1) YU49083B (no)

Families Citing this family (111)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5983956A (en) 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
US5863910A (en) * 1996-01-12 1999-01-26 Bolonick; Joel Treatment of chronic inflammatory disorders of the gastrointestinal tract
SE9603669D0 (sv) * 1996-10-08 1996-10-08 Astra Ab New combination
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9700135D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
ID24472A (id) * 1997-03-20 2000-07-20 Schering Corp Pembuatan aglomerat bubuk
SE9701956D0 (sv) 1997-05-23 1997-05-23 Astra Ab New composition of matter
JP2002510310A (ja) * 1997-06-27 2002-04-02 アストラ・アクチエボラーグ 抗喘息薬の新規配合
SE9703407D0 (sv) * 1997-09-19 1997-09-19 Astra Ab New use
AU766637B2 (en) * 1997-09-19 2003-10-23 Astrazeneca Ab New use for budesonide and formoterol
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
JP2002502812A (ja) * 1998-02-09 2002-01-29 ジョエル・ボロニック 胃腸管の慢性炎症疾患の治療
CN1289091C (zh) * 1998-02-11 2006-12-13 Rtp药品公司 治疗炎症的药物组合物和相关用途
SE9802073D0 (sv) * 1998-06-11 1998-06-11 Astra Ab New use
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6234167B1 (en) 1998-10-14 2001-05-22 Chrysalis Technologies, Incorporated Aerosol generator and methods of making and using an aerosol generator
DE19847969A1 (de) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Lagerfähig flüssige Formulierung mit Formoterol
RU2226103C2 (ru) * 1998-10-30 2004-03-27 Ивэкс Рисёч, Инк. Способы и композиции для предотвращения развития толерантности к лекарственным средствам
US6235725B1 (en) * 1998-10-30 2001-05-22 Baker Norton Pharmaceuticals, Inc. Methods and compositions for the prevention of tolerance to medications
HU226164B1 (en) 1998-11-13 2008-05-28 Jagotec Ag Use of magnesium stearate in dry powder compositions suitable for inhalation and compositions suitable for inhalation
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
GB9903759D0 (en) * 1999-02-18 1999-04-14 Novartis Ag Organic compounds
GB9904919D0 (en) 1999-03-03 1999-04-28 Novartis Ag Organic compounds
US20100197719A1 (en) * 1999-05-12 2010-08-05 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
US20040002548A1 (en) * 1999-05-12 2004-01-01 Boehringer Ingelheim Pharma Kg Medicament compositions containing anticholinergically-effective compounds and betamimetics
WO2001019367A1 (en) * 1999-09-13 2001-03-22 Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof
GB9928311D0 (en) * 1999-11-30 2000-01-26 Novartis Ag Organic compounds
CO5251465A1 (es) * 2000-01-26 2003-02-28 Pfizer Prod Inc Composiciones y procedimientos para tratar la osteoporosis y reducir el colesterol
US6369115B1 (en) 2000-03-20 2002-04-09 Dura Pharmaceuticals, Inc. Stabilized powder formulations
EP1274433A1 (en) * 2000-04-13 2003-01-15 Innovata Biomed Limited Medicaments for treating respiratory disorders comprising formoterol and fluticasone
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
US6883516B2 (en) 2000-04-27 2005-04-26 Chrysalis Technologies Incorporated Method for generating an aerosol with a predetermined and/or substantially monodispersed particle size distribution
MY136453A (en) 2000-04-27 2008-10-31 Philip Morris Usa Inc "improved method and apparatus for generating an aerosol"
GB0012261D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel process
GB0012260D0 (en) * 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
US20060257324A1 (en) * 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
FI20002215A0 (fi) * 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit
FI20002216A0 (fi) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Yhdistelmäpartikkelit astman hoitoon
US6799572B2 (en) 2000-12-22 2004-10-05 Chrysalis Technologies Incorporated Disposable aerosol generator system and methods for administering the aerosol
US6501052B2 (en) 2000-12-22 2002-12-31 Chrysalis Technologies Incorporated Aerosol generator having multiple heating zones and methods of use thereof
US7077130B2 (en) 2000-12-22 2006-07-18 Chrysalis Technologies Incorporated Disposable inhaler system
US6491233B2 (en) 2000-12-22 2002-12-10 Chrysalis Technologies Incorporated Vapor driven aerosol generator and method of use thereof
US6701921B2 (en) 2000-12-22 2004-03-09 Chrysalis Technologies Incorporated Aerosol generator having heater in multilayered composite and method of use thereof
US6681998B2 (en) 2000-12-22 2004-01-27 Chrysalis Technologies Incorporated Aerosol generator having inductive heater and method of use thereof
ITMI20010428A1 (it) * 2001-03-02 2002-09-02 Chemo Breath S A Composizioni ad uso inalatorio a base di formoterolo
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) * 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
US20050070487A1 (en) * 2001-04-24 2005-03-31 Nyce Jonathan W. Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
US6568390B2 (en) 2001-09-21 2003-05-27 Chrysalis Technologies Incorporated Dual capillary fluid vaporizing device
US6640050B2 (en) 2001-09-21 2003-10-28 Chrysalis Technologies Incorporated Fluid vaporizing device having controlled temperature profile heater/capillary tube
US7931022B2 (en) 2001-10-19 2011-04-26 Respirks, Inc. Method and apparatus for dispensing inhalator medicament
KR100951750B1 (ko) 2001-11-01 2010-04-09 노바르티스 아게 분무 건조 방법 및 그 조성물
US20030229058A1 (en) * 2001-11-13 2003-12-11 Moran Edmund J. Aryl aniline beta2 adrenergic receptor agonists
US6681769B2 (en) 2001-12-06 2004-01-27 Crysalis Technologies Incorporated Aerosol generator having a multiple path heater arrangement and method of use thereof
GB0129260D0 (en) * 2001-12-06 2002-01-23 Eisai London Res Lab Ltd Pharmaceutical compositions and their uses
US6804458B2 (en) 2001-12-06 2004-10-12 Chrysalis Technologies Incorporated Aerosol generator having heater arranged to vaporize fluid in fluid passage between bonded layers of laminate
US6701922B2 (en) 2001-12-20 2004-03-09 Chrysalis Technologies Incorporated Mouthpiece entrainment airflow control for aerosol generators
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
SE0200312D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
US20050009798A1 (en) 2002-02-20 2005-01-13 Sepracor Inc. Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
GB0219512D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Inhalation compositions with high drug ratios
AU2003263717A1 (en) * 2002-09-25 2004-04-19 Astrazeneca Ab A COMBINATION OF A LONG-ACTING Beta2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES
SE0203376D0 (sv) * 2002-11-15 2002-11-15 Astrazeneca Ab New process
DK1572217T3 (da) 2002-12-12 2008-12-15 Nycomed Gmbh Kombinationsmedikament af R,R-formoterol og ciclesonid
US7311790B2 (en) * 2003-04-25 2007-12-25 Siemens Power Generation, Inc. Hybrid structure using ceramic tiles and method of manufacture
SE527069C2 (sv) 2003-06-19 2005-12-13 Mederio Ag Förfarande och anordning för administrering av läkemedelspulver
SE527189C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser för formaterol och ett antikolinergiskt medel
SE526850C2 (sv) * 2003-06-19 2005-11-08 Microdrug Ag Farmaceutisk kombinerad torr pulverdos separerade på gemensam dosbädd
SE527190C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av en beta2-agonist, ett antikolinergiskt medel och ett antiinflammatorisk steroid
SE527200C2 (sv) * 2003-06-19 2006-01-17 Microdrug Ag Inhalatoranordning samt kombinerade doser av formaterol och fluticason
SE526509C2 (sv) * 2003-06-19 2005-09-27 Microdrug Ag Kombinerade doser av formoterol och budesonid separerade på en gemensam dosbädd
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
WO2005013963A1 (en) 2003-08-06 2005-02-17 Galephar M/F Advantageous combinations for inhalation of nacystelyn and bronchodilators
US7367334B2 (en) 2003-08-27 2008-05-06 Philip Morris Usa Inc. Fluid vaporizing device having controlled temperature profile heater/capillary tube
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
ES2353018T3 (es) 2004-07-16 2011-02-24 Almirall, S.A. Inhalador para la administración de productos farmacéuticos en polvo, y un cartucho de polvo para uso con este inhalador.
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
AU2006270165B2 (en) 2005-07-14 2010-03-11 Neothetics, Inc. Sustained release enhanced lipolytic formulation for regional adipose tissue treatment
US20070098644A1 (en) * 2005-10-31 2007-05-03 Richie's Pharmacy And Medical Supply, Incorporated Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease
US20070293460A1 (en) * 2005-10-31 2007-12-20 Richie's Pharmacy And Medical Supply, Incorporated Delivery of a combination therapy for asthma and chronic obstructive pulmonary disease
GB0604141D0 (en) * 2006-03-01 2006-04-12 Arrow Int Ltd Nebulizer formulation
GB2443287B (en) * 2006-10-17 2009-05-27 Lipothera Inc Methods, compositions and formulations for the treatment of thyroid eye disease
JP5564262B2 (ja) 2006-12-22 2014-07-30 アルミラル・ソシエダッド・アノニマ 粉末状薬剤のための吸入デバイス
EP1944018A1 (en) * 2007-01-10 2008-07-16 CHIESI FARMACEUTICI S.p.A. Micronised particles of low-dosage strength active agents for powder formulations for inhalation
PE20081788A1 (es) 2007-02-19 2008-12-18 Cipla Ltd Combinaciones farmaceuticas
EP1982709A1 (en) 2007-04-19 2008-10-22 CHIESI FARMACEUTICI S.p.A. Use of a composition comprising formoterol and beclomethasone dipropionate for the prevention or treatment of an acute condition of asthma
US8614255B2 (en) * 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations
US20100291221A1 (en) * 2009-05-15 2010-11-18 Robert Owen Cook Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
US9132084B2 (en) 2009-05-27 2015-09-15 Neothetics, Inc. Methods for administration and formulations for the treatment of regional adipose tissue
KR20120015334A (ko) 2009-05-29 2012-02-21 펄 테라퓨틱스 인코포레이티드 활성제의 호흡기 전달용 조성물, 및 연관된 방법 및 시스템
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
KR101638301B1 (ko) * 2010-01-15 2016-07-08 네오쎄틱스 인코포레이티드 동결건조 케이크 제제
CN102416179B (zh) 2010-09-28 2014-05-07 益得生物科技股份有限公司 用于哮喘的吸入性复方组合物
MX2013005873A (es) 2010-11-24 2013-08-07 Lithera Inc Formulaciones monoterapeuticas de agonistas beta selectivo, lipofilo y de accion prolongada y procedimientos para el tratamiento cosmetico de adiposidad y abultamiento del contorno.
WO2012154725A2 (en) * 2011-05-09 2012-11-15 University Of Houston Steroid-sparing effects of beta-adrenergic inverse agonists and use thereof
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
CN105188679B (zh) 2013-03-15 2018-10-16 珍珠治疗公司 用于微粒晶体材料的状态调节的方法和系统
GB201321717D0 (en) * 2013-12-09 2014-01-22 Pharmachemie Bv Inhalable Medicaments
GB201321712D0 (en) 2013-12-09 2014-01-22 Pharmachemie Bv Dry Powder Inhaler
GB201408387D0 (en) * 2014-05-12 2014-06-25 Teva Pharmaceuticals Europ B V Treatment of respiratory disorders
CA3007050C (en) 2015-12-04 2020-12-08 Mexichem Fluor S.A. De C.V. Pharmaceutical composition comprising a formoterol compound

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3994974A (en) * 1972-02-05 1976-11-30 Yamanouchi Pharmaceutical Co., Ltd. α-Aminomethylbenzyl alcohol derivatives
SE378109B (no) * 1972-05-19 1975-08-18 Bofors Ab
IL95590A (en) * 1989-09-08 1996-06-18 Glaxo Group Ltd Medicinal preparations containing Salmetrol and Pluticasone Propionate
JP3042866B2 (ja) * 1989-09-08 2000-05-22 グラクソ・グループ・リミテッド 呼吸疾患治療薬

Also Published As

Publication number Publication date
SK282826B6 (sk) 2002-12-03
DK0613371T3 (da) 2002-05-13
CZ291455B6 (cs) 2003-03-12
DE69232462D1 (de) 2002-04-11
CZ288032B6 (cs) 2001-04-11
HU9401843D0 (en) 1994-09-28
HUT75156A (en) 1997-04-28
CA2123909A1 (en) 1993-06-24
NO942116D0 (no) 1994-06-07
DE10299033I2 (de) 2005-07-07
SI9200403B (en) 2001-12-31
JPH07502036A (ja) 1995-03-02
SK73394A3 (en) 1995-03-08
HU227519B1 (en) 2011-07-28
WO1993011773A1 (en) 1993-06-24
NO306452B1 (no) 1999-11-08
DE10299033I1 (de) 2003-01-23
HU0004452D0 (no) 2001-01-29
HRP921445B1 (en) 2011-08-31
ATE213946T1 (de) 2002-03-15
US5674860A (en) 1997-10-07
CA2356145A1 (en) 1993-06-24
AU673660B2 (en) 1996-11-21
HK1010339A1 (en) 1999-06-17
YU106192A (sh) 1996-01-08
HRP921445A2 (en) 1994-12-31
US5972919A (en) 1999-10-26
CA2123909C (en) 2002-10-01
CZ143494A3 (en) 1994-12-15
NZ246050A (en) 1995-12-21
ES2172510T3 (es) 2002-10-01
SI9200403A (en) 1993-06-30
SK285910B6 (sk) 2007-10-04
SG48301A1 (en) 1998-04-17
AU3085892A (en) 1993-07-19
DE69232462T2 (de) 2002-10-10
JP3342484B2 (ja) 2002-11-11
IS3959A (is) 1993-06-19
PT613371E (pt) 2002-07-31
YU49083B (sh) 2003-10-31
AU673660C (en) 2002-07-25
NO942116L (no) 1994-06-07

Similar Documents

Publication Publication Date Title
NO2001014I2 (no) Symbicort turbuhaler
Atz et al. Sildenafil augments the effect of inhaled nitric oxide for postoperative pulmonary hypertensive crises
Ramirez-R Alveolar proteinosis: importance of pulmonary lavage
HUP9802093A2 (hu) Nitrogén-monoxid alkalmazása érrendszeri trombózis és restenózis kezelésére alkalmas gyógyszerkészítmény előállítására
EE04330B1 (et) Levosimendani transmukoossed koostised ja nende kasutamine ravimi valmistamiseks
DK0533896T3 (no)
CA2506962A1 (en) Synergistic combination comprising roflumilast and formoterol
ATE91890T1 (de) Herstellung eines arzneimittels gegen arthritis und rheumatismus.
RU93032284A (ru) Способ лечения заболевания легких
Lyons et al. The management of severe pulmonary emphysema
CA2506956A1 (en) Synergistic combination comprising roflumilast and (r,r)-formoterol
AR128201A1 (es) USO DE ÓXIDO NÍTRICO INHALADO (iNO) PARA TRATAR PACIENTES CON HIPERTENSIÓN PULMONAR ASOCIADA CON SARCOIDOSIS (PH-SARC)
AR002946A1 (es) Un conjunto para uso en el tratamiento o la prevencion de la osteoporosis en los mamiferos de acuerdo con una dieta ciclica.
CROMWELL et al. HYPERSENSITIVITY TO INTRAVENOUS MORPHINE SULFATE: Case Report
EP1249242B1 (en) Natural-Phytotherapic composition based on hydroglyceric extracts for aerosol therapy
Brock-Utne et al. Chest physiotherapy during mechanical ventilation
RU93002840A (ru) Способ лечения хронического гнойного эндобронхита
Garmash et al. Experience in the combined treatment of different clinical forms of chronic bronchitis with new phytotherapeutic mixtures
Meletis Cough Control the Natural Way
DITMYER JR Halothane insufflation for laryngoscopy
RU2002116988A (ru) Способ лечения хронических обструктивных болезней легких
Marks To wheeze or not to wheeze
Elliott A Brief Clinical Report of the Use of Brevital, 1/2 Per Cent, for General Anesthesia in Oral Surgery
Satoh et al. Is epidural buprenorphine with nitrous oxide-oxygen-enflurane anesthesia indicated for surgery of short-duration?
SE0000837D0 (sv) New use